You are here

Amgen

Citing J&J's 'failure to comply' with court rules, judge nixes early bid to block Amgen's Stelara biosim

Fierce Pharma

Fri, 03/3/23 - 11:56 am

Could This Humira Biosimilar Be a Winner for Amgen?

Motley Fool

Fri, 03/3/23 - 11:48 am

Junshi's lipid lowering drug hits phase 3 goals, teeing up challenge to Amgen, Sanofi in growth market

Fierce Biotech

Tue, 02/28/23 - 10:03 am

Junshi Biosciences

clinical trials

PCSK9 inhibitors

Fresenius Kabi introduces pegfilgrastim biosimilar for cancer patients in US

Pharmaceutical Business Review

Fri, 02/17/23 - 09:44 am

Years after the first US biosim launches, doctors still have their concerns: survey

Fierce Pharma

Thu, 02/16/23 - 04:49 pm

Amgen bond offering to help fund Horizon Therapeutics acquisition

Seeking Alpha

Thu, 02/16/23 - 11:26 am

Horizon Therapeutics

BioSpace Layoff Tracker 2023: Grifols, Frequency, Eliem and More Cut Staff

BioSpace

Thu, 02/16/23 - 11:18 am

Frequency Therapeutics

Eliem Therapeutics

Aligos Therapeutics

Thermo Fisher Scientific

Magenta Therapeutics

Y-mAbs Therapeutics

Century Therapeutics

Elevation Oncology

Calithera Biosciences

Editas Medicine

Layoffs continue to batter biotech, with Big Pharmas piling on the pain

Fierce Biotech

Wed, 02/1/23 - 10:32 pm

TCR2 Therapeutics

Moderna Therapeutics

Amgen Adopts A Two-Price Strategy For The U.S.’s First Marketed Humira-Referenced Biosimilar, Amjevita

Forbes

Wed, 02/1/23 - 10:41 am

Amgen launches Humira biosimilar, releases Q4 earnings report

Medical Marketing and Media

Tue, 01/31/23 - 11:21 pm

Humira biosimilars arrive in the US, as Amgen launches first copycat to AbbVie’s blockbuster drug

BioPharma Dive

Tue, 01/31/23 - 12:37 pm

Amgen commits $8m to improve clinical trial diversity

Outsourcing Pharma

Tue, 01/31/23 - 10:24 am

clinical trials

clinical trial diversity

Bristol Myers Squibb

Amgen, navigating 'industry headwinds,' puts 300 commercial jobs on chopping block

Fierce Pharma

Mon, 01/30/23 - 10:54 am

Warren keeps pressure on pharma, this time targeting Amgen and Indivior buyouts

Fierce Pharma

Mon, 01/30/23 - 10:41 am

Elizabeth Warren

Horizon Therapeutics

Opiant Pharmaceuticals

Amgen extends autoimmune pact with small Michigan biotech

Endpoints

Wed, 01/18/23 - 11:02 pm

autoimmune disease

Evoq Therapeutics

Amgen prepped to take first slice of AbbVie’s US Humira pie

BioProcess International

Wed, 01/18/23 - 11:00 pm

NewAmsterdam's Amgen castoff cuts LDL cholesterol in phase 2, opening new front in race to market

Fierce Biotech

Tue, 01/17/23 - 10:32 am

NewAmsterdam Pharma

CETP inhibitors

clinical trials

Big caps bounce back for biopharma

EP Vantage

Mon, 01/16/23 - 11:14 am

Bristol Myers Squibb

Gilead Sciences

Lantheus Holdings

Madrigal Pharmaceuticals

Moderna Therapeutics

Prometheus Biosciences

Biopharma’s bolt-on bonanza is set to continue

EP Vantage

Thu, 01/12/23 - 10:18 am

Bristol Myers Squibb

Amgen Boasts Lucrative Acquisitions, Drug Updates, Burgeoning Biosimilars at JPM

BioSpace

Tue, 01/10/23 - 06:43 pm

Pages